{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:27:00Z","timestamp":1786980420298,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T00:00:00Z","timestamp":1536192000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T00:00:00Z","timestamp":1536192000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R21AG057006"],"award-info":[{"award-number":["R21AG057006"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R21AG057006"],"award-info":[{"award-number":["R21AG057006"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL122863"],"award-info":[{"award-number":["R01HL122863"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Amino Acids"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s00726-018-2647-y","type":"journal-article","created":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T10:55:40Z","timestamp":1536231340000},"page":"97-102","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Biochemical characterization of the catecholaldehyde reactivity of l-carnosine and its therapeutic potential in human myocardium"],"prefix":"10.1007","volume":"51","author":[{"given":"Margaret-Ann M.","family":"Nelson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachariah J.","family":"Builta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Blake","family":"Monroe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.","family":"Doorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan J.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,6]]},"reference":[{"issue":"5","key":"2647_CR1","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/S0006-291X(02)02545-7","volume":"298","author":"G Aldini","year":"2002","unstructured":"Aldini G, Carini M, Beretta G, Bradamante S, Facino RM (2002a) Carnosine is a quencher of 4-hydroxy-nonenal: through what mechanism of reaction? Biochem Biophys Res Commun 298(5):699\u2013706","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"2647_CR2","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1002\/jms.381","volume":"37","author":"G Aldini","year":"2002","unstructured":"Aldini G, Granata P, Carini M (2002b) Detoxification of cytotoxic alpha, beta-unsaturated aldehydes by carnosine: characterization of conjugated adducts by electrospray ionization tandem mass spectrometry and detection by liquid chromatography\/mass spectrometry in rat skeletal muscle. J Mass Spectrom 37(12):1219\u20131228","journal-title":"J Mass Spectrom"},{"issue":"20","key":"2647_CR3","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1016\/j.jacc.2009.07.031","volume":"54","author":"EJ Anderson","year":"2009","unstructured":"Anderson EJ, Kypson AP, Rodriguez E, Anderson CA, Lehr EJ, Neufer PD (2009) Substrate-specific derangements in mitochondrial metabolism and redox balance in the atrium of the type 2 diabetic human heart. J Am Coll Cardiol 54(20):1891\u20131898","journal-title":"J Am Coll Cardiol"},{"issue":"30","key":"2647_CR4","doi-asserted-by":"publisher","first-page":"26978","DOI":"10.1074\/jbc.M111.249532","volume":"286","author":"DG Anderson","year":"2011","unstructured":"Anderson DG, Mariappan SV, Buettner GR, Doorn JA (2011) Oxidation of 3,4-dihydroxyphenylacetaldehyde, a toxic dopaminergic metabolite, to a semiquinone radical and an ortho-quinone. J Biol Chem 286(30):26978\u201326986","journal-title":"J Biol Chem"},{"issue":"1","key":"2647_CR5","doi-asserted-by":"publisher","first-page":"e000713","DOI":"10.1161\/JAHA.113.000713","volume":"3","author":"EJ Anderson","year":"2014","unstructured":"Anderson EJ, Efird JT, Davies SW, O\u2019Neal WT, Darden TM, Thayne KA, Katunga LA, Kindell LC, Ferguson TB, Anderson CA, Chitwood WR, Koutlas TC, Williams JM, Rodriguez E, Kypson AP (2014) Monoamine oxidase is a major determinant of redox balance in human atrial myocardium and is associated with postoperative atrial fibrillation. J Am Heart Assoc 3(1):e000713","journal-title":"J Am Heart Assoc"},{"issue":"7","key":"2647_CR6","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1021\/acs.chemrestox.5b00528","volume":"29","author":"DG Anderson","year":"2016","unstructured":"Anderson DG, Florang VR, Schamp JH, Buettner GR, Doorn JA (2016) Antioxidant-mediated modulation of protein reactivity for 3,4-dihydroxyphenylacetaldehyde, a toxic dopamine metabolite. Chem Res Toxicol 29(7):1098\u20131107","journal-title":"Chem Res Toxicol"},{"issue":"4","key":"2647_CR7","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1152\/physrev.00039.2012","volume":"93","author":"AA Boldyrev","year":"2013","unstructured":"Boldyrev AA, Aldini G, Derave W (2013) Physiology and pathophysiology of carnosine. Physiol Rev 93(4):1803\u20131845","journal-title":"Physiol Rev"},{"issue":"2","key":"2647_CR8","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2174\/1568007033482913","volume":"2","author":"WJ Burke","year":"2003","unstructured":"Burke WJ (2003) 3,4-dihydroxyphenylacetaldehyde: a potential target for neuroprotective therapy in Parkinson\u2019s disease. Curr Drug Targets CNS Neurol Disord 2(2):143\u2013148","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"issue":"2","key":"2647_CR9","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0006-8993(03)03354-7","volume":"989","author":"WJ Burke","year":"2003","unstructured":"Burke WJ, Li SW, Williams EA, Nonneman R, Zahm DS (2003) 3,4-dihydroxyphenylacetaldehyde is the toxic dopamine metabolite in vivo: implications for Parkinson\u2019s disease pathogenesis. Brain Res 989(2):205\u2013213","journal-title":"Brain Res"},{"issue":"1\u20132","key":"2647_CR10","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0161-813X(03)00090-1","volume":"25","author":"WJ Burke","year":"2004","unstructured":"Burke WJ, Li SW, Chung HD, Ruggiero DA, Kristal BS, Johnson EM, Lampe P, Kumar VB, Franko M, Williams EA, Zahm DS (2004) Neurotoxicity of MAO metabolites of catecholamine neurotransmitters: role in neurodegenerative diseases. Neurotoxicology 25(1\u20132):101\u2013115","journal-title":"Neurotoxicology"},{"issue":"9","key":"2647_CR11","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1002\/jms.517","volume":"38","author":"M Carini","year":"2003","unstructured":"Carini M, Aldini G, Beretta G, Arlandini E, Facino RM (2003) Acrolein-sequestering ability of endogenous dipeptides: characterization of carnosine and homocarnosine\/acrolein adducts by electrospray ionization tandem mass spectrometry. J Mass Spectrom 38(9):996\u20131006","journal-title":"J Mass Spectrom"},{"issue":"16","key":"2647_CR12","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1002\/cmdc.201500552","volume":"11","author":"M Colzani","year":"2016","unstructured":"Colzani M, De Maddis D, Casali G, Carini M, Vistoli G, Aldini G (2016) Reactivity, selectivity, and reaction mechanisms of aminoguanidine, hydralazine, pyridoxamine, and carnosine as sequestering agents of reactive carbonyl species: a comparative study. Chem Med Chem 11(16):1778\u20131789","journal-title":"Chem Med Chem"},{"issue":"Suppl 1","key":"2647_CR13","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.1016\/S1353-8020(13)70019-1","volume":"20","author":"JA Doorn","year":"2014","unstructured":"Doorn JA, Florang VR, Schamp JH, Vanle BC (2014) Aldehyde dehydrogenase inhibition generates a reactive dopamine metabolite autotoxic to dopamine neurons. Parkinsonism Relat Disord 20(Suppl 1):S73\u2013S75","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"2647_CR14","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1124\/pr.56.3.1","volume":"56","author":"G Eisenhofer","year":"2004","unstructured":"Eisenhofer G, Kopin IJ, Goldstein DS (2004) Catecholamine metabolism: a contemporary view with implications for physiology and medicine. Pharmacol Rev 56(3):331\u2013349","journal-title":"Pharmacol Rev"},{"issue":"4631","key":"2647_CR15","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/182311a0","volume":"182","author":"JH Fellman","year":"1958","unstructured":"Fellman JH (1958) The rearrangement of epinephrine. Nature 182(4631):311\u2013312","journal-title":"Nature"},{"issue":"1","key":"2647_CR16","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.neuro.2006.07.018","volume":"28","author":"VR Florang","year":"2007","unstructured":"Florang VR, Rees JN, Brogden NK, Anderson DG, Hurley TD, Doorn JA (2007) Inhibition of the oxidative metabolism of 3,4-dihydroxyphenylacetaldehyde, a reactive intermediate of dopamine metabolism, by 4-hydroxy-2-nonenal. Neurotoxicology 28(1):76\u201382","journal-title":"Neurotoxicology"},{"key":"2647_CR17","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/B978-0-12-411512-5.00012-9","volume":"68","author":"DS Goldstein","year":"2013","unstructured":"Goldstein DS (2013) Biomarkers, mechanisms, and potential prevention of catecholamine neuron loss in Parkinson disease. Adv Pharmacol 68:235\u2013272","journal-title":"Adv Pharmacol"},{"issue":"6","key":"2647_CR18","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1111\/j.1471-4159.2012.07924.x","volume":"123","author":"DS Goldstein","year":"2012","unstructured":"Goldstein DS, Sullivan P, Cooney A, Jinsmaa Y, Sullivan R, Gross DJ, Holmes C, Kopin IJ, Sharabi Y (2012) Vesicular uptake blockade generates the toxic dopamine metabolite 3,4-dihydroxyphenylacetaldehyde in PC12 cells: relevance to the pathogenesis of Parkinson\u2019s disease. J Neurochem 123(6):932\u2013943","journal-title":"J Neurochem"},{"key":"2647_CR19","doi-asserted-by":"publisher","unstructured":"Gostimskaya I, Galkin A (2010) Preparation of highly coupled rat heart mitochondria. J Vis Exp 23(43). https:\/\/doi.org\/10.3791\/2202","DOI":"10.3791\/2202"},{"issue":"1","key":"2647_CR20","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0014-5793(95)00849-5","volume":"371","author":"AR Hipkiss","year":"1995","unstructured":"Hipkiss AR, Michaelis J, Syrris P (1995) Non-enzymatic glycosylation of the dipeptide l-carnosine, a potential anti-protein-cross-linking agent. FEBS Lett 371(1):81\u201385","journal-title":"FEBS Lett"},{"issue":"5","key":"2647_CR21","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1021\/tx800405v","volume":"22","author":"Y Jinsmaa","year":"2009","unstructured":"Jinsmaa Y, Florang VR, Rees JN, Anderson DG, Strack S, Doorn JA (2009) Products of oxidative stress inhibit aldehyde oxidation and reduction pathways in dopamine catabolism yielding elevated levels of a reactive intermediate. Chem Res Toxicol 22(5):835\u2013841","journal-title":"Chem Res Toxicol"},{"issue":"1\u20132","key":"2647_CR22","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.cbi.2011.01.006","volume":"192","author":"Y Jinsmaa","year":"2011","unstructured":"Jinsmaa Y, Florang VR, Rees JN, Mexas LM, Eckert LL, Allen EM, Anderson DG, Doorn JA (2011) Dopamine-derived biological reactive intermediates and protein modifications: implications for Parkinson\u2019s disease. Chem Biol Interact 192(1\u20132):118\u2013121","journal-title":"Chem Biol Interact"},{"issue":"8","key":"2647_CR24","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/S0891-5849(01)00484-1","volume":"30","author":"BS Kristal","year":"2001","unstructured":"Kristal BS, Conway AD, Brown AM, Jain JC, Ulluci PA, Li SW, Burke WJ (2001) Selective dopaminergic vulnerability: 3,4-dihydroxyphenylacetaldehyde targets mitochondria. Free Radic Biol Med 30(8):924\u2013931","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"2647_CR25","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0006-8993(00)02309-X","volume":"868","author":"I Lamensdorf","year":"2000","unstructured":"Lamensdorf I, Eisenhofer G, Harvey-White J, Nechustan A, Kirk K, Kopin IJ (2000) 3,4-Dihydroxyphenylacetaldehyde potentiates the toxic effects of metabolic stress in PC12 cells. Brain Res 868(2):191\u2013201","journal-title":"Brain Res"},{"issue":"4","key":"2647_CR26","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.neuro.2011.03.013","volume":"32","author":"LM Mexas","year":"2011","unstructured":"Mexas LM, Florang VR, Doorn JA (2011) Inhibition and covalent modification of tyrosine hydroxylase by 3,4-dihydroxyphenylacetaldehyde, a toxic dopamine metabolite. Neurotoxicology 32(4):471\u2013477","journal-title":"Neurotoxicology"},{"issue":"5","key":"2647_CR27","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1111\/j.1471-4159.1987.tb05702.x","volume":"48","author":"GE Nilsson","year":"1987","unstructured":"Nilsson GE, Tottmar O (1987) Biogenic aldehydes in brain: on their preparation and reactions with rat brain tissue. J Neurochem 48(5):1566\u20131572","journal-title":"J Neurochem"},{"issue":"2","key":"2647_CR28","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0021-9258(17)35225-0","volume":"266","author":"MA Paz","year":"1991","unstructured":"Paz MA, Fluckiger R, Boak A, Kagan HM, Gallop PM (1991) Specific detection of quinoproteins by redox-cycling staining. J Biol Chem 266(2):689\u2013692","journal-title":"J Biol Chem"},{"issue":"10","key":"2647_CR29","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1021\/tx700248y","volume":"20","author":"JN Rees","year":"2007","unstructured":"Rees JN, Florang VR, Anderson DG, Doorn JA (2007) Lipid peroxidation products inhibit dopamine catabolism yielding aberrant levels of a reactive intermediate. Chem Res Toxicol 20(10):1536\u20131542","journal-title":"Chem Res Toxicol"},{"issue":"7","key":"2647_CR30","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1021\/tx9000557","volume":"22","author":"JN Rees","year":"2009","unstructured":"Rees JN, Florang VR, Eckert LL, Doorn JA (2009) Protein reactivity of 3,4-dihydroxyphenylacetaldehyde, a toxic dopamine metabolite, is dependent on both the aldehyde and the catechol. Chem Res Toxicol 22(7):1256\u20131263","journal-title":"Chem Res Toxicol"},{"issue":"2","key":"2647_CR31","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.bbrc.2017.08.067","volume":"492","author":"BC Vanle","year":"2017","unstructured":"Vanle BC, Florang VR, Murry DJ, Aguirre AL, Doorn JA (2017) Inactivation of glyceraldehyde-3-phosphate dehydrogenase by the dopamine metabolite, 3,4-dihydroxyphenylacetaldehyde. Biochem Biophys Res Commun 492(2):275\u2013281","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"2647_CR32","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1016\/0006-2952(93)90632-7","volume":"46","author":"L Wlodek","year":"1993","unstructured":"Wlodek L, Rommelspacher H, Susilo R, Radomski J, Hofle G (1993) Thiazolidine derivatives as source of free l-cysteine in rat tissue. Biochem Pharmacol 46(11):1917\u20131928","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"2647_CR33","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1021\/jf980780j","volume":"47","author":"S Zhou","year":"1999","unstructured":"Zhou S, Decker EA (1999) Ability of carnosine and other skeletal muscle components to quench unsaturated aldehydic lipid oxidation products. J Agric Food Chem 47(1):51\u201355","journal-title":"J Agric Food Chem"}],"container-title":["Amino Acids"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00726-018-2647-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-018-2647-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-018-2647-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T17:12:38Z","timestamp":1661965958000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00726-018-2647-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,6]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["2647"],"URL":"https:\/\/doi.org\/10.1007\/s00726-018-2647-y","relation":{},"ISSN":["0939-4451","1438-2199"],"issn-type":[{"value":"0939-4451","type":"print"},{"value":"1438-2199","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,6]]},"assertion":[{"value":"9 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of human rights"}},{"value":"As described above in \u201c\n                      \n                      \u201d, informed consent was obtained from all participants involved in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}